Skip to content

Climb Bio, Inc. CLYM Retained Earnings

Retained Earnings at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$18.29B+13.5%
Amgen logo
AmgenAMGN
-$24.65B+9.2%
Vera Therapeutics logo
Vera TherapeuticsVERA
-$881.9M-71.9%
Kyverna Therapeutics, Inc. logo
Kyverna Therapeutics, Inc.KYTX
-$464.56M-50.8%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-$637.78M-53.0%
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
-$214.76M+8.8%

Other financials

Income statement

See full
Operating income-$15.2M+33.9%
Net income-$13.7M+34.0%
EPS (diluted)-$0.20+35.5%

Balance sheet

See full
Cash & equivalents$8.4M-71.2%
Total debt$479.0K+1.1%
Total equity$148.1M-23.4%
Total assets$152.4M-24.1%

Cash flow

See full
Operating cash flow-$14.4M+6.8%
CapEx$109.0K
Free cash flow-$15.6M-183%

Valuation

See full
Market cap$724.95M+787%
Enterprise value$717.07M+1,247%

Returns & leverage

See full
Return on equity-30.9%-10.3pp
Debt / equity0.0×
Current ratio27.9×+13.6×

Where this comes from

Reported directly by Climb Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Climb Bio, Inc.'s retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Climb Bio, Inc.'s retained earnings?
Climb Bio, Inc. (CLYM) reported retained earnings of -$303.45M in Q1 2026.
How has Climb Bio, Inc.'s retained earnings changed year-over-year?
Climb Bio, Inc.'s retained earnings decreased by 21.1% year-over-year, from -$250.66M to -$303.45M.
What is the long-term trend for Climb Bio, Inc.'s retained earnings?
Over 5 years (2020 to 2025), Climb Bio, Inc.'s retained earnings has grown at a 59.4% compound annual growth rate (CAGR), from -$28.14M to -$289.73M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.